Therapeutic agent reduces age-related sleep problems in fruit flies

April 1, 2014
The fruit fly Drosophila melanogaster has a life expectancy of approx. 8 weeks and belongs to the model organisms studied by scientists at the Max Planck Institute for Biology of Ageing in their quest to understand aging in living beings. Credit: MPI f. Biology of Ageing/ W. Weiss

Elderly flies do not sleep well – they frequently wake up during the night and wander around restlessly. The same is true of humans. For researchers at the Max Planck Institute for Biology of Ageing in Cologne, the sleeplessness experienced by the fruit fly Drosophila is therefore a model case for human sleeping behaviour. The scientists have now discovered molecules in the flies' cells that affect how the animals sleep in old age: if insulin/IGF signalling is active, the quality of the animals' sleep is reduced and they wake up more often. Using a therapeutic agent, researchers managed to improve the flies' sleep again. The scientists suspect that the causes of sleep problems experienced by older flies and humans are similar. It is also possible that sleep problems encountered by humans may not necessarily be an inevitable side effect of ageing and may even be reversible.

Flies and humans in much the same way. Just like us, sleep during the night and are active during the day. And the quality of sleep deteriorates as both species age: the individuals nap more frequently during the day and sleep for shorter periods at night.

Gerontologists are very familiar with the insulin/IGF (insulin-like growth factor) signalling pathway. It is actually a metabolic pathway that controls the cell's response to nutritional deficiency and also affects life expectancy. Fruit flies therefore live longer if the signalling pathway is less active. The signalling pathway also plays a role in ageing humans.

Researchers at the Cologne-based Max Planck Institute have now discovered that fruit flies sleep better at night and are more active during the day if insulin/IGF signalling is inhibited. "Daytime activity and night-time sleep are thereby controlled by two different components: during the day, the neurotransmitter octopamine and the adipokinetic hormone AKH increase activity in flies. At night, on the other hand, the neurotransmitter dopamine and the kinase TOR reduce the sleep periods," explains Luke Tain from the Max Planck Institute for Biology of Ageing.

Rapamycin is a substance that inhibits TOR activity, inhibiting the molecule. "We administered rapamycin to older flies and observed that they once again slept for longer periods. As a result, we were able to reverse the deterioration in as a consequence of ageing," says Tain.

The cells of such different organisms as roundworms, flies and humans use the insulin/IGF signalling pathway. Its components and function are similar in various species of living organisms. The researchers now want to study whether the signal molecules in higher animals, such as mice, have the same effect. In this way, they hope to discover treatments that will improve sleep quality in old age.

Explore further: Scientists wake up to causes of sleep disruption in Alzheimer's disease

More information: Athanasios Metaxakis, Luke S. Tain, Sebastian Grönke, Oliver Hendrich, Yvonne Hinze, Ulrike Birras & Linda Partridge , Lowered Insulin Signalling Ameliorates Age-Related Sleep Fragmentation in Drosophila , PLoS Biology, 2 April 2014. www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1001824

Related Stories

Researchers identify gene that helps fruit flies go to sleep

March 13, 2014

In a series of experiments sparked by fruit flies that couldn't sleep, Johns Hopkins researchers say they have identified a mutant gene—dubbed "Wide Awake"—that sabotages how the biological clock sets the timing for sleep. ...

New fruitfly sleep gene promotes the need to sleep

February 4, 2014

All creatures great and small, including fruitflies, need sleep. Researchers have surmised that sleep – in any species—is necessary for repairing proteins, consolidating memories, and removing wastes from cells. But, ...

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

TET proteins drive early neurogenesis

December 7, 2016

The fate of stem cells is determined by series of choices that sequentially narrow their available options until stem cells' offspring have found their station and purpose in the body. Their decisions are guided in part by ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.